Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment.
NPJ Breast Cancer. 2022 May 20;8(1):66. doi: 10.1038/s41523-022-00434-w.
NPJ Breast Cancer. 2022.
PMID: 35595761
Free PMC article.
Evolution of HER2-low expression from primary to recurrent breast cancer.
Miglietta F, Griguolo G, Bottosso M, Giarratano T, Lo Mele M, Fassan M, Cacciatore M, Genovesi E, De Bartolo D, Vernaci G, Amato O, Conte P, Guarneri V, Dieci MV.
Miglietta F, et al.
NPJ Breast Cancer. 2021 Oct 12;7(1):137. doi: 10.1038/s41523-021-00343-4.
NPJ Breast Cancer. 2021.
PMID: 34642348
Free PMC article.
Item in Clipboard
Cite
Cite